← FDA Drug Approvals (Drugs@FDA)

DARUNAVIR AND RITONAVIR

NDA · New Drug Application · Sponsor: MYLAN PHARMS INC · Approved 2023-12-22

Drug application

FDA Application #

NDA209847

Application type

New Drug Application

Brand name

DARUNAVIR AND RITONAVIR

Generic name

Darunavir And Ritonavir

Active ingredients

DARUNAVIR AND RITONAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MYLAN PHARMS INC

First approval

2023-12-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown